Trial Search Results

Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Cesarean Delivery

The purpose of the study is to assess potential age-related differences on coagulation profile of patients undergoing Cesarean Section, using thromboelastography (TEG). The investigators will compare coagulation data collected from the study to assess potential differences in coagulation parameters for the following age groups: (i) women less than 35 yrs (ii) women 35 yrs or older.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


Inclusion Criteria:

   - All obstetric patients with singleton pregnancies admitted to the labor and delivery
   unit at LPCH who undergo elective Cesarean delivery with neuraxial anesthesia.

   - We will enroll only healthy patients with singleton pregnancies and whose pregnancy is
   not result of in vitro fertilization.

Exclusion Criteria:

   - Patients with underlying coagulation disorders.

   - Patients with thrombocytopenia.

   - Patients with pregnancy-induced hypertension, pre-eclampsia.

   - Patients requiring the following medications prior to surgery: non-steroidal
   anti-inflammatories, aspirin, anticoagulants.

   - Patients requiring non-elective Cesarean delivery.

   - Patients with significant obstetric or medical disease.

   - No patients <18 years of age will be recruited.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alexander J Butwick, MBBS, FRCA